Associate Nanoparticle Formulation Scientist

Phosphorex, Inc.; Hopkinton (MA); On-site; USD 60,000 - 80,000; Full time

Job summary

Phosphorex, Inc. in Hopkinton is seeking an Associate Scientist to specialize in the formulation and characterization of drug delivery systems. The role involves optimizing formulations for cell targeting, including hands-on laboratory work and collaboration with multidisciplinary teams.

The ideal candidate will have a Bachelor’s degree in a relevant field and strong analytical skills, along with the ability to manage multiple priorities in a fast-paced environment. Experience with microfluidics and biodegradable polymers is preferred, contributing to innovative therapeutic developments.

Qualifications

• 0-2 years relevant experience in drug delivery systems.
• Ability to manage multiple priorities in a fast-paced environment.
• Demonstrated ability to work independently and within a team.

Responsibilities

• Assist in optimization of drug delivery systems for nucleic acids and peptides.
• Prepare polymeric and lipid-based formulations via microfluidics.
• Characterize formulations including particle size analysis and drug content.
• Collaborate with project teams to facilitate project plans.
• Maintain laboratory notebook and adhere to safety practices.

Skills

Analytical thinking

Organizational skills

Verbal communication

Written communication

Microsoft Office

Education

Bachelor’s degree in chemistry, pharmacy, pharmaceutical sciences, engineering, or relevant discipline

Job description

Phosphorex, Inc. in Hopkinton is seeking an Associate Scientist to specialize in the formulation and characterization of drug delivery systems. The role involves optimizing formulations for cell targeting, including hands-on laboratory work and collaboration with multidisciplinary teams.

The ideal candidate will have a Bachelor’s degree in a relevant field and strong analytical skills, along with the ability to manage multiple priorities in a fast-paced environment. Experience with microfluidics and biodegradable polymers is preferred, contributing to innovative therapeutic developments.